Opening the pill case of a diabetic patient in India, there is always a high chance to see two or sometimes three medicines combined into one single dose. This is the result of an in-depth formulation thinking we pursue as a diabetology pharma manufacturer India brands trust for creating the medicines for the diabetic patients.
India’s diabetic problems are growing by the day, and the medicine addressing the issues is becoming more and more complex.
Let’s discuss the main aspects of any serious diabetology portfolio and see why we have built our reputation on offering the most reliable diabetology pharma manufacturer India solutions for brands.
Why Diabetes Care Demands Specialized Manufacturers
India is one of the countries with the highest numbers of diabetic patients in the world. Hence, there are numerous brands looking for a reliable diabetology pharma manufacturer India for creating high-quality medicines.
The treatment for diabetes rarely involves one or two drugs only because there is always a need to address multiple aspects of the disease: glucose levels, insulin production and usage, kidney functionality, and others.
Thus, a decent manufacturer of anti-diabetic tablets India deals with highly complicated forms of combination therapies to ensure that each patient gets a full course of treatment.
An Overview of the Diabetology Catalog Offered
We have created a comprehensive range of anti-diabetic medications that brands can choose from and integrate various aspects of diabetes treatment. Here are the key elements that our diabetology pharma manufacturer India solutions cover:
- Metformin-based formulations are the backbone of any serious diabetes treatment nowadays, and we have both immediate and sustained release options in our catalog
- Sulfonylureas are another important class of anti-diabetic medicines with which we can create dosage forms of Gliclazide, Glibenclamide, and Glimepiride, combine them with Metformin, and offer the resulting combination therapy in both immediate and sustained release forms
- Gliptins are a large class of DPP-4 inhibitors that can be used in diabetes treatment, and we have Sitagliptin, Vildagliptin, Linagliptin, Teneligliptin, each available in mono and combination with other anti-diabetic drugs in our portfolio
- Dapagliflozin and Empagliflozin are part of the SGLT2-inhibitor class of medications for diabetes that can also be used in combination with other drugs
- Pioglitazone is an insulin sensitizer that we can use in mono, dual, and triple combination therapies
- Repaglinide is a meglitinide available in mono formulations
One of the notable advantages of our diabetes care catalog is that many of its elements can serve as a fixed-dose combination platform for developing new combination therapies, including those featuring a Gliptin, an SGLT2 inhibitor, and Metformin.
As a trusted Metformin Gliptin manufacturer India clinics choose, we know what a combination therapy means to a patient, and we strive to make their use as convenient as possible: smaller size of the dosage form means better adherence to the treatment regimen.
Where iMickro Nano Technology Makes a Difference
There is a common sense belief among patients that the bigger the pill, the worse it is for them. Hence, a diabetic patient that has to take three drugs per day in the form of three separate tablets is likely to experience difficulties swallowing them all.
A combination therapy can address this problem by incorporating three active pharmaceutical ingredients into a single dosage form. However, the resulting pill will also be large and may be refused by the patient.
Our proprietary iMickro Nano technology for diabetes tablets enables a significant reduction in tablet size while designing fixed-dose combination therapies of Metformin with other anti-diabetic medications. This is an important feature that brings our diabetology manufacturing partners considerable advantages over their competitors.
Namely, when developing dosage forms with a combination of Glimepiride, Pioglitazone, and Metformin, we can make a smaller pill that will also be easier on the patient’s stomach.
Such advancements in the field of diabetes care are highly valued by brands that choose to cooperate with us as their diabetology contract manufacturing partner instead of a generic manufacturer.
Challenges of Combination Therapies
A single-tablet formulation manufacturing is a challenge for any pharmaceutical manufacturer. However, a combination therapy implies the use of multiple active ingredients.
The following properties should be taken into consideration when designing such a dosage form:
- Uniformity of the mixture within a tablet
- Stability of the resulting mix
- Bioavailability of each active ingredient contained in the tablet
- Dissolution profiles
And other features peculiar to sustained and extended release formulations.
Each of these aspects plays a crucial role in the creation of an effective combination therapy. Thus, it is important to choose the right diabetology pharma manufacturer India that will be able to address all these points during the development process.
Why Brands Choose to Partner With Us
In the course of developing our diabetology portfolio, we have built upon a solid understanding of the needs of both patients and manufacturers of anti-diabetic medications India is a trusted partner for.
With our experience in the field, we understand that the creation of a combination therapy presupposes a careful balance of multiple factors that can affect the fate of the drug in the body after intake.
Therefore, our team of specialists conducts extensive research to ensure that the characteristics of the new dosage form correspond to the needs of the future patients and can be fulfilled with the equipment at our disposal.
By choosing an experienced diabetology pharma manufacturer India, companies address the critical importance of developing a medication with balanced properties and high quality while also reducing the time of the development due to the absence of manufacturing-related issues.
Whether a company wants to create a new brand of diabetes care medication or expand its portfolio with anti-diabetic drugs, a seasoned diabetology pharma manufacturer India is the best choice due to the variety of solutions and the high level of manufacturing expertise.
Conclusion
The issues addressed by diabetes care medications keep evolving, and the same can be said about the medicine itself. It takes years of research to perfect a single aspect of drug development and bring a working solution to market.
That is why we invite all brands interested in diabetes care to learn more about our diabetology range and manufacturing expertise as valuable allies in their endeavor to enter the lucrative diabetic care market.
